Sumitomo Pharma Co., Ltd. (4506.T)
JPY 523.0
(0.97%)
JPY 523.0
(0.97%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 907.5 Billion JPY | -20.03% |
| 2022 | 1134.74 Billion JPY | -13.25% |
| 2021 | 1308 Billion JPY | -0.01% |
| 2020 | 1308.12 Billion JPY | 4.41% |
| 2019 | 1252.87 Billion JPY | 50.1% |
| 2018 | 834.71 Billion JPY | 3.09% |
| 2017 | 809.68 Billion JPY | 1.98% |
| 2016 | 793.95 Billion JPY | 12.19% |
| 2015 | 707.71 Billion JPY | -0.54% |
| 2014 | 711.58 Billion JPY | 7.97% |
| 2013 | 659.03 Billion JPY | 8.53% |
| 2012 | 607.21 Billion JPY | 8.55% |
| 2011 | 559.41 Billion JPY | -5.16% |
| 2010 | 589.86 Billion JPY | -5.88% |
| 2009 | 626.74 Billion JPY | 60.17% |
| 2008 | 391.29 Billion JPY | -2.13% |
| 2007 | 399.79 Billion JPY | 4.51% |
| 2006 | 382.53 Billion JPY | -2.65% |
| 2005 | 392.96 Billion JPY | 95.09% |
| 2004 | 201.43 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 868.93 Billion JPY | -4.25% |
| 2024 Q2 | 799.76 Billion JPY | -7.96% |
| 2023 FY | 907.5 Billion JPY | -20.03% |
| 2023 Q2 | 1148.85 Billion JPY | 0.71% |
| 2023 Q3 | 1059.97 Billion JPY | -7.74% |
| 2023 Q4 | 907.5 Billion JPY | -14.38% |
| 2023 Q1 | 1140.7 Billion JPY | 0.53% |
| 2022 Q2 | 1407.95 Billion JPY | -1.05% |
| 2022 Q1 | 1422.93 Billion JPY | 8.79% |
| 2022 FY | 1134.74 Billion JPY | -13.25% |
| 2022 Q4 | 1134.74 Billion JPY | -17.26% |
| 2022 Q3 | 1371.51 Billion JPY | -2.59% |
| 2021 Q3 | 1295.91 Billion JPY | 2.25% |
| 2021 Q4 | 1308 Billion JPY | 0.93% |
| 2021 FY | 1308 Billion JPY | -0.01% |
| 2021 Q1 | 1276.7 Billion JPY | -2.4% |
| 2021 Q2 | 1267.43 Billion JPY | -0.73% |
| 2020 Q3 | 1308.83 Billion JPY | 5.68% |
| 2020 Q2 | 1238.48 Billion JPY | 0.19% |
| 2020 FY | 1308.12 Billion JPY | 4.41% |
| 2020 Q1 | 1236.18 Billion JPY | -1.33% |
| 2020 Q4 | 1308.12 Billion JPY | -0.05% |
| 2019 FY | 1252.87 Billion JPY | 50.1% |
| 2019 Q4 | 1252.87 Billion JPY | 12.35% |
| 2019 Q3 | 1115.15 Billion JPY | 38.52% |
| 2019 Q2 | 805.03 Billion JPY | -0.37% |
| 2019 Q1 | 808.06 Billion JPY | -3.19% |
| 2018 Q1 | 820.24 Billion JPY | 1.3% |
| 2018 Q4 | 834.71 Billion JPY | 0.56% |
| 2018 Q3 | 830.06 Billion JPY | -0.76% |
| 2018 FY | 834.71 Billion JPY | 3.09% |
| 2018 Q2 | 836.43 Billion JPY | 1.97% |
| 2017 Q2 | 828.54 Billion JPY | 2.48% |
| 2017 Q1 | 808.49 Billion JPY | 1.83% |
| 2017 FY | 809.68 Billion JPY | 1.98% |
| 2017 Q4 | 809.68 Billion JPY | -3.82% |
| 2017 Q3 | 841.81 Billion JPY | 1.6% |
| 2016 Q4 | 793.95 Billion JPY | 5.73% |
| 2016 Q1 | 658.08 Billion JPY | -7.01% |
| 2016 Q2 | 641.15 Billion JPY | -2.57% |
| 2016 FY | 793.95 Billion JPY | 12.19% |
| 2016 Q3 | 750.94 Billion JPY | 17.12% |
| 2015 Q2 | 726.01 Billion JPY | -0.18% |
| 2015 FY | 707.71 Billion JPY | -0.54% |
| 2015 Q3 | 756.59 Billion JPY | 4.21% |
| 2015 Q4 | 707.71 Billion JPY | -6.46% |
| 2015 Q1 | 727.31 Billion JPY | 2.21% |
| 2014 Q3 | 716.91 Billion JPY | 6.88% |
| 2014 Q2 | 670.76 Billion JPY | 5.07% |
| 2014 Q1 | 638.38 Billion JPY | -3.13% |
| 2014 FY | 711.58 Billion JPY | 7.97% |
| 2014 Q4 | 711.58 Billion JPY | -0.74% |
| 2013 Q1 | 634.03 Billion JPY | 4.42% |
| 2013 Q3 | 658.19 Billion JPY | 3.72% |
| 2013 FY | 659.03 Billion JPY | 8.53% |
| 2013 Q4 | 659.03 Billion JPY | 0.13% |
| 2013 Q2 | 634.56 Billion JPY | 0.08% |
| 2012 FY | 607.21 Billion JPY | 8.55% |
| 2012 Q2 | 579.15 Billion JPY | -0.53% |
| 2012 Q3 | 573.84 Billion JPY | -0.92% |
| 2012 Q1 | 582.21 Billion JPY | 4.08% |
| 2012 Q4 | 607.21 Billion JPY | 5.82% |
| 2011 FY | 559.41 Billion JPY | -5.16% |
| 2011 Q1 | 581.74 Billion JPY | -1.38% |
| 2011 Q3 | 554.18 Billion JPY | -2.14% |
| 2011 Q2 | 566.29 Billion JPY | -2.66% |
| 2011 Q4 | 559.41 Billion JPY | 0.94% |
| 2010 Q3 | 588.24 Billion JPY | -2.27% |
| 2010 Q4 | 589.86 Billion JPY | 0.28% |
| 2010 Q2 | 601.9 Billion JPY | -3.66% |
| 2010 Q1 | 624.76 Billion JPY | -0.32% |
| 2010 FY | 589.86 Billion JPY | -5.88% |
| 2009 Q3 | 667.14 Billion JPY | 69.24% |
| 2009 FY | 626.74 Billion JPY | 60.17% |
| 2009 Q4 | 626.74 Billion JPY | -6.06% |
| 2009 Q2 | 394.21 Billion JPY | 0.0% |
| 2008 Q4 | 391.29 Billion JPY | 0.0% |
| 2008 FY | 391.29 Billion JPY | -2.13% |
| 2007 FY | 399.79 Billion JPY | 4.51% |
| 2006 FY | 382.53 Billion JPY | -2.65% |
| 2005 FY | 392.96 Billion JPY | 95.09% |
| 2004 FY | 201.43 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -2381.355% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 93.994% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 35.952% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -5784.851% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | -244.53% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -428.779% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 34.89% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -5181.418% |
| Hisamitsu Pharmaceutical Co., Inc. | 328.77 Billion JPY | -176.023% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -471.477% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -1086.903% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -1731.569% |
| Tsumura & Co. | 428.25 Billion JPY | -111.908% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | -247.798% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -580.126% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | -110.728% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -963.5% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -502.859% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -410.756% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -5931.543% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -1067.841% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -5811.304% |
| MedRx Co., Ltd | 2.05 Billion JPY | -44125.439% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -4689.373% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -35488.471% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -44694.649% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -872.55% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | -137.552% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -21431.367% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | -17.336% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -2735.6% |